ESGO 2023 congress, September 28-October 1, 2023, in Istanbul, Türkiye, Europe's largest Gynaecological Oncology gathering, celebrates 40 years of excellence with the best minds and legends in the field

Scientific Programme Highlights

› ESGO Congress: A Global Stage of Gynaecological Oncology Best Practice and Research

The ESGO 2023 Congress kicks off with an exciting 4-day programme on September 28, 2023.

This year's congress will highlight the latest clinical and scientific developments in gynaecological cancers, with more than 50 scientific sessions delivered by renowned international experts focusing on a variety of topics driving research, treatment and care forward.

Don't miss the very best of gynaecological oncology practice and research, latest findings, practical take-home messages and a wealth of knowledge for your daily practice.

Join us in Istanbul for ESGO 2023, the largest gathering in the field of gynaecological oncology!

› ESGO 2023 Programme: More Opportunities to Advance Your Knowledge

Live surgery performed from hospitals of recognized prestige where you can assess different surgical perspectives.
Exclusive State of the Art Sessions in the treatment of gynaecological tumours following the ESGO clinical guidelines
Debates Sessions on hot controversial topics
Practice-changing Trials in 2023: update on the scientific advances in the results of the latest clinical trials that are changing daily practice.
Current options for sparing fertility treatment
Latest advances in chemotherapy, radiotherapy, and immunotherapy
New Emerging Pathways and Targeted Treatments in gynaecological cancers
Most recent translational research, including biomarkers, liquid biopsies, and antibody-drug conjugates.
Video Sessions of the latest Surgical and Imaging Techniques
Tumour Board Sessions
Oral Presentations of the best abstracts
ENYGO Programme designed for young gynaecological oncologists
2-day Patient Advocacy Seminar organised by ENGAGe

and much more...

Topics will include the newest aspects in (molecular) diagnostics, surgical, radiotherapeutic and medical concepts, as well as tailored strategies at the time of diagnosis and recurrent disease.

Surgical approaches have been subjected to changes and individualisation, based on both tumour characteristics and patients’ needs.

Improved knowledge about tumour biology and the implementation of new biomarkers has led to new trends of personalised medicine and the selection of patients for individualised treatment.